A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)
(Q43470687)
scientific article published on November 1, 1997
scientific article published on November 1, 1997
Language: